KNSA (Kiniksa Pharmaceuticals) Short-Term Debt to Capital
Kiniksa Pharmaceuticals (KNSA) monetizes therapies for rare inflammatory processes, leveraging patent protection and consistent demand. The market trend for the stock price reflects the value of 0.00. Business revenues are based on the sale of ARCALYST for the treatment of autoimmune pathologies. Meanwhile, Kiniksa Pharmaceuticals (KNSA) is optimizing raw material procurement to eliminate supply chain disruptions and ensure the continuous production of medications.
Analytical breakdowns for Kiniksa Pharmaceuticals
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Kiniksa Pharmaceuticals|KNSA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Kiniksa|KNSA - Aggregate Debt Obligations|Debts to Book Capitalization Kiniksa Pharmaceuticals, Ltd.|KNSA - Long-Term Debt Volume|Company Short-Term Debt Kiniksa|Quick Liquidity kiniksa.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Kiniksa Pharmaceuticals Ltd
This ratio determines the extent of the company's dependence on short-term liabilities relative to its equity, measuring liquidity risk and the level of financial leverage. By analyzing the short-term debt-to-equity ratio on the GURU.Markets platform, an investor assesses the ability of Kiniksa Pharmaceuticals (KNSA) to finance laboratory robotization and the implementation of drug distribution software without incurring a critical debt burden.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Grifols Group (GRFS) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital auriniapharma.com|Short-Term Debt to Equity Ratio BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital DNTH (Dianthus Pharma)|Short-Term Debt to Capital Coefficient Pharvaris Pharma (PHVS)|ABCL - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|SEPN - Short-Term Debt to Equity|PVLA - Short-Term Debt to Capital|SVRA: Short-Term Debt to Capital|RIGL - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity AnaptysBio|Short-Term Debt to Capital Ratio ATXS (Astria Therapeutics Inc)|Short-Term Debt to Capital ENGN|Short-Term Debt to Capital Coefficient rapt.com|Short-Term Debt to Equity Aerovate Therapeutics JBIO|Short-Term Debt to Capital aclaristx.com ACRS|KYTX - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Tiziana Life Sciences Ltd. TLSA|CABA: Short-Term Debt to Capital|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio THTX|AVTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Eledon Pharmaceuticals, Inc. (ELDN)|AGEN: Current Liabilities to Equity|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|Ratio of Short-Term Indebtedness to Capital ZURA|aTyr Pharma, Inc. - Short-Term Debt to Capital|ADAG - Short-Term Debt to Capital|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Shattuck Labs - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Equillium Inc|Short-Term Debt to Equity Ratio Connect Pharma (CNTB)|Short-Term Debt to Capital IMUX|Short-Term Debt to Capital atarabio.com (ATRA)|Short-Term Debt to Capital IFRX (InflaRx)|XFOR - Short-Term Debt to Equity Ratio|Adicet - Short-Term Debt to Capital|Current Liabilities to Capital Celularity Inc.|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|barinthusbio.com (BRNS) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio KZR|SABS (SAB Biotherapeutics Inc.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Capital QTTB (Q32 Bio)|GOVX - Short-Term Debt to Equity Ratio|Edesa Biotech - Short-Term Debt to Capital|IBIO - Short-Term Debt to Capital|carismatx.com (CARM) - Short-Term Debt to Equity|XTLB (XTL Bio) - Short-Term Debt to Equity|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc (HCWB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI: Short-Term Debt to Capital Ratio|XRTX - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient reshapelifesciences.com HIND|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Scinai|CalciMedica Corp - Current Liabilities to Equity|Short-Term Debt to Capital AFMD|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com